How Do Nocebo Phenomena Provide a Theoretical Framework for the COVID-19 Pandemic?
COVID-19 pandemic
mood changes
negative expectation
nocebo effects in randomised controlled trials
nocebo responses in brain imaging studies
psychosocial context
Journal
Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902
Informations de publication
Date de publication:
2020
2020
Historique:
received:
31
07
2020
accepted:
24
09
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
17
11
2020
Statut:
epublish
Résumé
The COVID-19 pandemic is a major health issue, which leads to psychological and behavioural changes. In particular, among various negative feelings, fear seems to be one of the main emotional reactions that can be as contagious as the virus itself. The actual pandemic is likely to function as an important stressor, especially in terms of chronic anxiety and lack of control over the succession of unforeseeable environmental events. In this direction, the psychological impact of previous quarantine measures showed important negative psychological effects, including post-traumatic stress symptoms (PTTS) with long-lasting effects. The presence of psychological discomfort and disturbances due to negative contextual factors can be studied using the nocebo phenomenon as a possible theoretical explanatory framework. Although in the absence of studies linking nocebo to Covid-19 and data-driven evidence, the context of the actual pandemic may be seen as a fertile ground for amplified discomfort and anxiety. The media provide dramatic and negative descriptions and often present conflicting sources of information, which can lead to physical and mental health problems, diminishing response to treatment. This can be worse when supported by conspiracy theories or misinformation. The aim of this perspective review is to propose a new theoretical framework for the COVID-19 pandemic, which should be supported by future empirical studies. In particular, the negative contextual factors, which can predispose individuals to psychological distress and the onset of the nocebo phenomena will be presented here, in order to suggest possible guidelines to mitigate the devastating effects of COVID-19.
Identifiants
pubmed: 33192929
doi: 10.3389/fpsyg.2020.589884
pmc: PMC7661580
doi:
Types de publication
Journal Article
Langues
eng
Pagination
589884Informations de copyright
Copyright © 2020 Amanzio, Howick, Bartoli, Cipriani and Kong.
Références
SSM Popul Health. 2019 May 04;8:100402
pubmed: 31193417
Psychiatry Res. 2020 May;287:112921
pubmed: 32240896
Cleve Clin J Med. 2007 Feb;74 Suppl 1:S8-16
pubmed: 17455536
Psychopharmacology (Berl). 2001 May;155(3):230-3
pubmed: 11432684
J Neurosci. 2008 Dec 3;28(49):13354-62
pubmed: 19052227
Front Psychiatry. 2020 Feb 26;11:72
pubmed: 32174851
Neuroscience. 2007 Jun 29;147(2):260-71
pubmed: 17379417
Trials. 2018 Dec 11;19(1):674
pubmed: 30526685
J Neurosci. 2006 Nov 15;26(46):12014-22
pubmed: 17108175
Am J Public Health. 2009 Oct;99 Suppl 2:S324-32
pubmed: 19797744
Neuroimage. 2015 May 15;112:197-207
pubmed: 25776211
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Int Clin Psychopharmacol. 2010 Mar;25(2):83-90
pubmed: 20065855
Hum Brain Mapp. 2015 May;36(5):1648-61
pubmed: 25529840
J Med Ethics. 2020 Feb 16;:
pubmed: 32063581
Expert Rev Clin Pharmacol. 2015 Mar;8(2):159-61
pubmed: 25494811
Psychiatry Clin Neurosci. 2020 Jun;74(6):372
pubmed: 32248608
Handb Exp Pharmacol. 2014;225:3-15
pubmed: 25304523
Lancet Psychiatry. 2020 Mar;7(3):e14
pubmed: 32035030
Hum Brain Mapp. 2013 Mar;34(3):738-52
pubmed: 22125184
Lancet Psychiatry. 2020 Jul;7(7):611-627
pubmed: 32437679
JAMA. 2017 Dec 26;318(24):2425-2426
pubmed: 29090307
Am J Bioeth. 2012;12(3):22-9
pubmed: 22416745
Br J Psychol. 2020 Feb;111(1):17-35
pubmed: 30868563
Front Pharmacol. 2019 May 17;10:502
pubmed: 31156432
J Clin Psychopharmacol. 2016 Oct;36(5):475-82
pubmed: 27580494
Expert Rev Clin Pharmacol. 2020 Feb;13(2):75-77
pubmed: 31995411
JAMA. 2002 Feb 6;287(5):622-7
pubmed: 11829702
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714